Leukemia News and Features
Current research indicates that a rare but aggressive subtype of pediatric acute lymphoblastic leukemia (ALL) has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.
Acute lymphoblastic leukemia (ALL) has been found to have two distinct subtypes, and evidence indicates that roughly 13% of ALL cases may be successfully treated with targeted drugs used in the treatment of lymphomas in adults.
Breastfeeding a child may reduce that child's risk of developing pediatric acute lymphoblastic leukemia (ALL).
Presence of this protein indicates a likely toxicity effect associated with chemotherapy in acute myeloid leukemia (AML).
Children with acute lymphoblastic leukemia with a certain gene variant experienced a higher incidence and severity of peripheral neuropathy after receiving treatment with the cancer drug vincristine, according to a study.
Leukemia Clinical Trials
- Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
- Counseling cancer patients on effective nutritional practices
- Childhood leukemia study reveals disease subtypes and new treatment options
- Radiation plus immunotherapy revs up immune system to better attack melanoma
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Scent-trained dog detects thyroid cancer in human urine samples
- Report shows U.S. cancer deaths on the decline
- Leafy green vegetables may slow mental deterioration
- Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
- Risk of breast cancer in transgender persons studied in veterans
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|